Brain surgery has always been a high-stakes gamble. Surgeons are hampered by a lack of data, relying on pre-operative scans and intuition when every millimeter matters.
Clee Medical plans to change that. The Swiss startup, co-founded by Matt Lapinski and Abed Hammoud (EMBA 2004), has developed real-time imaging and sensing technology that gives brain surgeons greater precision and visualization during operations.
“If we can tell surgeons where they actually are […] brain surgery is much more efficient, there are better patient outcomes, unlocking new targets in the brain,” explains Lapinski.
Watch Lapinski reveal what drives him, where Clee Medical stands in its development journey, the make-or-break challenges over the next 12-18 months, and his personal highs of the entrepreneurship journey.